The ESE acts as the voice of its members on the issues that matter to them. We actively engage in advocacy: encouraging government organisations to better support the needs of our members.
In order to best represent them, ESE actively seeks the views of its members across Europe. The ESE Council of Affiliated Societies (ECAS) provides a forum for our National Affiliated Societies. ECAS helps us to understand opportunities, challenges and developments, and initiate pan-European programmes benefiting endocrinology.
The European Society of Endocrinology represents more than 20 000 endocrinologists through direct membership and affiliated societies. We amplify these voices by combining influence with other societies as a member of collaborative advocacy groups. Through our association with Alliance for Biomedical Research in Europe, Initiative for Science in Europe and the European Medicines Agency, we hope to drive real change in policy and improve opportunities available to endocrine researchers throughout Europe.
As we increase our advocacy activity we plan to narrow our focus towards the issues that have greatest effect on our members. We will regularly update you about our activities and ensure that interested parties have the chance to provide their input.
ESE: The Voice for Endocrinology
ESE’s Mission Statement -‘Shaping the Future of Endocrinology’ - requires that we actively engage with different stakeholders in creating a European and broader international environment that recognises the important place of ‘endocrine’ health in the development of future health care policies and support to research programmes.
- ESE: The Voice for Endocrinology
- ESE & Policy and Advocacy
- ESE & COVID-19 and EU4Health
- ESE & Endocrine Disrupting Chemicals in the EU
- ESE & EU Beating Cancer Plan
If you want to become more engaged in ESE Policy and Advocacy activities please complete this form.
LAUNCH EVENT ON ‘WHY HORMONES MATTER IN EU HEALTH POLICY’ – ESE’ WHITE PAPER
The European Society of Endocrinology (ESE) is organising a webinar to present its new White Paper on endocrinology, titled “Hormones in European Health Policies: How endocrinologists can contribute towards a healthier Europe”. The webinar will feature high level policy makers, experts and other interested parties to discuss ‘why hormones matter in EU health policy’.
The event will introduce the interlinkages between endocrinology and COVID-19 and will have specific dedicated sessions for four important health topics: obesity, cancer, rare diseases and endocrine disrupting chemicals. For each topic, a discussion will take place between involved policymakers and expert endocrinologists.
The event will take place on Tuesday 4 May 2021 from 10:00 to 12:00 noon CEST. You can register using the following link:
This historical document, first of its kind in Europe, has now received endorsement of 45 National Endocrine Societies and seven ESE associated Specialist Societies representing the vast majority of the more than 20,000 Endocrinologists across Europe. We hope that you share our vision that it is a milestone in the life of ESE and a tremendous step toward the path of inclusion which we started two years ago and now brings our Society to be key in the creation of a true Global Endocrine community and as a trustworthy and proactive partner of European Institutions.
ESE & COVID-19 and EU4Health.
ESE’s experts have been very active since the pandemic started, identifying links between COVID-19 and endocrinology. Our latest position paper on the topic can be found here. Recently (15 February 2021) Member of the European Parliament (MEP) Sirpa Pietikäinen (Finland, European People’s Party) echoed our call for a stronger policy response in the Parliament Magazine. Read her article here.
ENDOCRINE DISRUPTING CHEMICALS
ESE's EDC Working Group has been very active since 2019. You can follow ESE's activities on EDCs here.
ESE's Policy and Advocacy Working Group (launched in late 2019) have been following the European Commission's 'Beating Cancer Roadmap' with interest and presented a submission to this in March 2019.
ESE Statement following the publication of Europe’s Beating Cancer Plan on 3 February 2021: The European Society of Endocrinology (ESE) welcomes the European Commission Beating Cancer Plan, presented on 3 February 2021, ahead of World Cancer Day. A strong focus on cancer and holistic approach is needed to make a difference for the many people and their families suffering from this disease. The Beating Cancer Plan touches upon many of ESE’s key priorities - read more in our Statement.
ORGANISATIONS ESE IS WORKING WITH INCLUDE:
Read more about the organisations with which ESE is working to deliver its advocacy activities: